Catalent Inc
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies;… Read more
Catalent Inc (CTLT) - Total Assets
Latest total assets as of September 2024: $9.71 Billion USD
Based on the latest financial reports, Catalent Inc (CTLT) holds total assets worth $9.71 Billion USD as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Catalent Inc - Total Assets Trend (2012–2024)
This chart illustrates how Catalent Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Catalent Inc - Asset Composition Analysis
Current Asset Composition (June 2024)
Catalent Inc's total assets of $9.71 Billion consist of 26.6% current assets and 73.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.0% |
| Accounts Receivable | $1.57 Billion | 16.1% |
| Inventory | $574.00 Million | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $841.00 Million | 8.6% |
| Goodwill | $2.33 Billion | 23.9% |
Asset Composition Trend (2012–2024)
This chart illustrates how Catalent Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Catalent Inc's current assets represent 26.6% of total assets in 2024, an increase from 22.5% in 2012.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2024, down from 4.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, a decrease from 45.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 23.9% of total assets.
Catalent Inc Competitors by Total Assets
Key competitors of Catalent Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Catalent Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Catalent Inc generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Catalent Inc is currently not profitable relative to its asset base.
Catalent Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.51 | 1.71 | 1.98 |
| Quick Ratio | 1.96 | 1.19 | 1.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.51 Billion | $ 1.10 Billion | $ 642.40 Million |
Catalent Inc - Advanced Valuation Insights
This section examines the relationship between Catalent Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.25 |
| Latest Market Cap to Assets Ratio | 1.17 |
| Asset Growth Rate (YoY) | -9.5% |
| Total Assets | $9.75 Billion |
| Market Capitalization | $11.45 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Catalent Inc's assets above their book value (1.17 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Catalent Inc's assets decreased by 9.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Catalent Inc (2012–2024)
The table below shows the annual total assets of Catalent Inc from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | $9.75 Billion | -9.54% |
| 2023-06-30 | $10.78 Billion | +2.62% |
| 2022-06-30 | $10.51 Billion | +15.31% |
| 2021-06-30 | $9.11 Billion | +17.17% |
| 2020-06-30 | $7.78 Billion | +25.75% |
| 2019-06-30 | $6.18 Billion | +36.48% |
| 2018-06-30 | $4.53 Billion | +31.17% |
| 2017-06-30 | $3.45 Billion | +11.75% |
| 2016-06-30 | $3.09 Billion | -1.73% |
| 2015-06-30 | $3.15 Billion | +1.79% |
| 2014-06-30 | $3.09 Billion | +1.09% |
| 2013-06-30 | $3.06 Billion | -2.62% |
| 2012-06-30 | $3.14 Billion | -- |